GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NervGen Pharma Corp (TSXV:NGEN) » Definitions » Net Interest Income (for Banks)

NervGen Pharma (TSXV:NGEN) Net Interest Income (for Banks)


View and export this data going back to 2019. Start your Free Trial

What is NervGen Pharma Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


NervGen Pharma (TSXV:NGEN) Business Description

Industry
Traded in Other Exchanges
Address
2955 Virtual Way, Suite 480, Vancouver, BC, CAN, V5M 4X6
NervGen Pharma Corp is a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases. The company is developing drugs for the treatment of spinal cord injury, multiple sclerosis, and Alzheimer's disease. It operates in a single segment, which is the research and development of pharmaceutical drugs.